The Research and Development Center for Precision Medicine (PMC) was established as Japan’s first omics analysis center aiming to develop a $1000 genome sequencing technology. Using state-of-the-art technologies in genome sequencing and mass spectrometry, the Center aims to provide analytic and translational approaches to provide precise diagnosis of cancers and various diseases in a data-driven/evidencebased approach.
The Center has been working with the Tsukuba Preventive Medicine Research Center, which offers a comprehensive medical examination utilizing the function of initiative prevention of medical research. In order to promote collaborations with leading domestic and international research institutions, the PMC is also active in crossbordermultidisciplinary networking.
The Center aims to establish a research infrastructure for the implementation and realization of Precision Medicine, to improve/determine the best course of treatment for each individual.
Research findings of Eiji Sugihara, Ph.D. were issued a press release both at University of Tsukuba and Keio University.
Published in Biological Psychiatry (2020.08.01)
Joint research between PMC and Prof. Seiji Ogawa of Tumor Biology Dept. of Kyoto University was published in Nature.
2019.10.10 Research findings of Jun Mukai, MD, Ph.D., who previously worked at Columbia University were issued a press release at University of Tsukuba.
2019.10.24 Research findings of Jun Mukai, MD, Ph.D., who previously worked at Columbia University were issued a press release at National Institute of Health(NIH) in the US.